The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

Benefit-Risk

Download it: MP3 | AAC | OGG | OPUS

Key points:

  • Benefit-risk assessments: Evolution in healthcare evaluations.
  • Patient preferences: Importance in benefit-risk evaluations.
  • Tommi Tervonen: Chief Scientist at Kielo Research, an expert in MCDA and patient preferences.
  • Experience: Nearly two decades in benefit-risk assessments.
  • Structured methodologies: Importance in benefit-risk decisions.
  • Patient-centric approaches: Role in shaping healthcare choices.
  • Past, present, and future: Exploration of benefit-risk assessments.
  • Healthcare decisions: Impact of patient input and structured assessments.

We explore the critical role of benefit-risk assessments in healthcare, the importance of patient preferences, and how these elements shape informed decisions. Tommi's insights provided a deep understanding of the evolution and future trends in this field.

If you found this discussion valuable, share this episode with your friends and colleagues who can benefit from understanding the importance of structured methodologies and patient-centric approaches in healthcare. Let's spread the knowledge and contribute to more informed and effective healthcare decisions.


Comments


New comment

By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.

About this podcast

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.

by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry

Subscribe

Follow us